Change Theme
CNBC TV18
Fri, Aug 30, 2024
Biocon arm Biocon Pharma receives US FDA approval for Daptomycin injection
Shares of Biocon Ltd ended at ₹359.30, up by ₹4.05, or 1.14% on the BSE.